Structural basis for reduced ribosomal A-site fidelity in response to P-site codon–anticodon mismatches
Journal of Biological Chemistry · 2023
DOI: 10.1016/j.jbc.2023.104608 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Ha An Nguyen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Emory University, Atlanta, Georgia, USA; Emory Antibiotic Resistance Center (ARC), Emory University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Anticodon, Codon, Ribosomes, RNA, Ribosomal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, U.S. Department of Defense, U.S. Department of Energy.
Abstract (Originalsprache)
Rapid and accurate translation is essential in all organisms to produce properly folded and functional proteins. mRNA codons that define the protein-coding sequences are decoded by tRNAs on the ribosome in the aminoacyl (A) binding site. The mRNA codon and the tRNA anticodon interaction is extensively monitored by the ribosome to ensure accuracy in tRNA selection. While other polymerases that synthesize DNA and RNA can correct for misincorporations, the ribosome is unable to correct mistakes. Instead, when a misincorporation occurs, the mismatched tRNA-mRNA pair moves to the peptidyl (P) site and, from this location, causes a reduction in the fidelity at the A site, triggering post-peptidyl transfer quality control. This reduced fidelity allows for additional incorrect tRNAs to be accepted and for release factor 2 (RF2) to recognize sense codons, leading to hydrolysis of the aberrant peptide. Here, we present crystal structures of the ribosome containing a tRNALys in the P site with a U•U mismatch with the mRNA codon. We find that when the mismatch occurs in the second position of the P-site codon-anticodon interaction, the first nucleotide of the A-site codon flips from the mRNA path to engage highly conserved 16S rRNA nucleotide A1493 in the decoding center. We propose that this mRNA nucleotide mispositioning leads to reduced fidelity at the A site. Further, this state may provide an opportunity for RF2 to initiate premature termination before erroneous nascent chains disrupt the cellular proteome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Emory University, Atlanta, Georgia, USA; Emory Antibiotic Resistance Center (ARC), Emory University, Atlanta, Georgia, USA.
- Emory Antibiotic Resistance Center (ARC), Emory University, Atlanta, Georgia, USA; Biochemistry, Cell and Developmental Biology Graduate Program, Emory University, Atlanta, Georgia, USA.
- Department of Chemistry, Emory University, Atlanta, Georgia, USA; Emory Antibiotic Resistance Center (ARC), Emory University, Atlanta, Georgia, USA. Electronic address: christine.m.dunham@emory.edu.
Förderung
- NIGMS NIH HHS
- U.S. Department of Defense
- U.S. Department of Energy
- National Institute of General Medical Sciences
- Office of Science
- Argonne National Laboratory
- National Institutes of Health
- National Defense Science and Engineering Graduate
Zitieren
APA
Nguyen, H. A., Hoffer, E. D., Fagan, C. E., Maehigashi, T., & Dunham, C. M. (2023). Structural basis for reduced ribosomal A-site fidelity in response to P-site codon–anticodon mismatches. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.104608
Vancouver
Nguyen HA, Hoffer ED, Fagan CE, Maehigashi T, Dunham CM. Structural basis for reduced ribosomal A-site fidelity in response to P-site codon–anticodon mismatches. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.104608
BibTeX
@article{Nguyen2023,
author = {Nguyen, Ha An and Hoffer, Eric D and Fagan, Crystal E and Maehigashi, Tatsuya and Dunham, Christine M},
title = {Structural basis for reduced ribosomal A-site fidelity in response to P-site codon–anticodon mismatches},
journal = {Journal of Biological Chemistry},
year = {2023},
doi = {10.1016/j.jbc.2023.104608}
}
EUVIMED